Liver study tests drug processing in impaired patients
NCT ID NCT05919069
First seen Feb 22, 2026 · Last updated May 21, 2026 · Updated 12 times
Summary
This study looked at how a single dose of the experimental drug AZD2693 is handled by the body in people with liver impairment compared to healthy volunteers. A total of 35 adults took part, receiving one injection under the skin. The main goal was to measure drug levels in the blood and check for any safety issues. This research helps doctors understand if liver problems affect how the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Rialto, California, 92377, United States
-
Research Site
Miami Lakes, Florida, 33014, United States
-
Research Site
Orlando, Florida, 32808, United States
Conditions
Explore the condition pages connected to this study.